COVID-19 and Bacillus Calmette-Guérin: What is the Link?

Paul K. Hegarty; John P. Sfakianos; Gianluca Giannarini; Andrew R. DiNardo; Ashish M. Kamat

doi:10.1016/j.euo.2020.04.001

COVID-19 and Bacillus Calmette-Guérin: What is the Link?

Paul K. Hegarty, John P. Sfakianos, Gianluca Giannarini, Andrew R. DiNardo, Ashish M. Kamat

Urology

Research output: Contribution to journal › Editorial › peer-review

55 Scopus citations

Abstract

The debate around the role of vaccination with Bacillus Calmette-Guérin has revived right in the time of the Coronavirus disease 19 pandemic. Since Bacillus Calmette-Guérin is one of the most commonly delivered therapies in urology, in this editorial we discuss some points that we think will be of interest and guidance to practicing urologists during this public health emergency.

Original language	English (US)
Pages (from-to)	259-261
Number of pages	3
Journal	European Urology Oncology
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.euo.2020.04.001
State	Published - Jun 1 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.euo.2020.04.001

Cite this

@article{e54296722c6e475f9fafa933679c3751,

title = "COVID-19 and Bacillus Calmette-Gu{\'e}rin: What is the Link?",

abstract = "The debate around the role of vaccination with Bacillus Calmette-Gu{\'e}rin has revived right in the time of the Coronavirus disease 19 pandemic. Since Bacillus Calmette-Gu{\'e}rin is one of the most commonly delivered therapies in urology, in this editorial we discuss some points that we think will be of interest and guidance to practicing urologists during this public health emergency.",

author = "Hegarty, {Paul K.} and Sfakianos, {John P.} and Gianluca Giannarini and DiNardo, {Andrew R.} and Kamat, {Ashish M.}",

year = "2020",

month = jun,

day = "1",

doi = "10.1016/j.euo.2020.04.001",

language = "English (US)",

volume = "3",

pages = "259--261",

journal = "European Urology Oncology",

issn = "2588-9311",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - COVID-19 and Bacillus Calmette-Guérin

T2 - What is the Link?

AU - Hegarty, Paul K.

AU - Sfakianos, John P.

AU - Giannarini, Gianluca

AU - DiNardo, Andrew R.

AU - Kamat, Ashish M.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - The debate around the role of vaccination with Bacillus Calmette-Guérin has revived right in the time of the Coronavirus disease 19 pandemic. Since Bacillus Calmette-Guérin is one of the most commonly delivered therapies in urology, in this editorial we discuss some points that we think will be of interest and guidance to practicing urologists during this public health emergency.

AB - The debate around the role of vaccination with Bacillus Calmette-Guérin has revived right in the time of the Coronavirus disease 19 pandemic. Since Bacillus Calmette-Guérin is one of the most commonly delivered therapies in urology, in this editorial we discuss some points that we think will be of interest and guidance to practicing urologists during this public health emergency.

UR - http://www.scopus.com/inward/record.url?scp=85085469575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085469575&partnerID=8YFLogxK

U2 - 10.1016/j.euo.2020.04.001

DO - 10.1016/j.euo.2020.04.001

M3 - Editorial

C2 - 32327396

AN - SCOPUS:85085469575

SN - 2588-9311

VL - 3

SP - 259

EP - 261

JO - European Urology Oncology

JF - European Urology Oncology

IS - 3

ER -

COVID-19 and Bacillus Calmette-Guérin: What is the Link?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this